NCT00706017View on ClinicalTrials.gov

Observational Study to Evaluate the Safety of Levemir® in Diabetes

CompletedOBSERVATIONAL
Enrollment

2,282

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Mexico City

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY